Literature DB >> 28550714

Adherence to oral cancer therapy in older adults: The International Society of Geriatric Oncology (SIOG) taskforce recommendations.

Anna Rachelle Mislang1, Tanya M Wildes2, Ravindran Kanesvaran3, Capucine Baldini4, Holly M Holmes5, Ginah Nightingale6, Annemarie Coolbrandt7, Laura Biganzoli8.   

Abstract

There is an increasing trend towards using oral systemic therapy in patients with cancer. Compared to parenteral therapy, oral cancer agents offer convenience, have similar efficacy, and are preferred by patients, consequently making its use appealing in older adults. However, adherence is required to ensure its efficacy and to avoid compromising treatment outcomes, especially when the treatment goal is curative, or in case of symptomatic/rapidly progressing disease, where dose-intensity is important. This opens a new challenge for clinicians, as optimizing patient adherence is challenging, particularly due to lack of consensus and scarcity of available clinical evidence. This manuscript aims to review the impact of age-related factors on adherence, summarize the evidence on adherence, recommend methods for selecting patients suitable for oral cancer agents, and advise monitoring interventions to promote adherence to treatment.
Copyright © 2017. Published by Elsevier Ltd.

Entities:  

Keywords:  Adherence; Geriatric oncology; Oral cancer agents; Toxicity

Mesh:

Year:  2017        PMID: 28550714     DOI: 10.1016/j.ctrv.2017.05.002

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN: 0305-7372            Impact factor:   12.111


  19 in total

Review 1.  Approach to the treatment of the older, unfit patient with myeloma from diagnosis to relapse: perspectives of a US hematologist and a geriatric hematologist.

Authors:  Tanya M Wildes; Kenneth C Anderson
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

Review 2.  Using Information Technology in the Assessment and Monitoring of Geriatric Oncology Patients.

Authors:  Kah Poh Loh; Colin McHugh; Supriya G Mohile; Karen Mustian; Marie Flannery; Heidi Klepin; Rebecca Schnall; Eva Culakova; Erika Ramsdale
Journal:  Curr Oncol Rep       Date:  2018-03-06       Impact factor: 5.075

3.  Adherence to Lenalidomide in Older Adults With Newly Diagnosed Multiple Myeloma.

Authors:  Hira Mian; Mark Fiala; Tanya M Wildes
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2019-10-09

4.  High adherence of patients with multiple myeloma who receive treatment with immunomodulatory drugs (IMIDS) in hematology/oncology group practices in Germany.

Authors:  Stefan Feiten; Geothy Chakupurakal; Hans Peter Feustel; Michael Maasberg; Burkhard Otremba; Peter Ehscheidt; Manfred Hensel; Richard Hansen; Rudolf Weide
Journal:  Support Care Cancer       Date:  2019-03-11       Impact factor: 3.603

5.  Adherence to abiraterone or enzalutamide in elderly metastatic castration-resistant prostate cancer.

Authors:  Giuseppe L Banna; Valeria Urzia; Chiara Benanti; Alessandra Pitrè; Helga Lipari; Rosario Di Quattro; Ugo De Giorgi; Giuseppe Schepisi; Umberto Basso; Davide Bimbatti; Francesco Rundo; Massimo Libra; Lorenzo Malatino
Journal:  Support Care Cancer       Date:  2020-01-20       Impact factor: 3.603

6.  ONS Guidelines™ to Support Patient Adherence to Oral Anticancer Medications.

Authors:  Sarah M Belcher; Emily Mackler; Benyam Muluneh; Pamela K Ginex; Mary K Anderson; Elizabeth Bettencourt; Ryan K DasGupta; Jennifer Elliott; Erica Hall; Michelle Karlin; Diana Kostoff; Victoria K Marshall; Vanessa E Millisor; Maegan Molnar; Susan M Schneider; Janelle Tipton; Susan Yackzan; Kristine B LeFebvre; Kapeena Sivakumaran; Haya Waseem; Rebecca L Morgan
Journal:  Oncol Nurs Forum       Date:  2022-06-17       Impact factor: 1.803

7.  Oral adherence in adults with acute myeloid leukemia (AML): results of a mixed methods study.

Authors:  Ashley Leak Bryant; Thomas W LeBlanc; Tara Albrecht; Ya-Ning Chan; Jaime Richardson; Matthew Foster; Malisa Dang; William Dudley; Susie Owenby; Debra Wujcik
Journal:  Support Care Cancer       Date:  2020-02-14       Impact factor: 3.603

Review 8.  Toxicity of Cancer Therapies in Older Patients.

Authors:  Olivia Le Saux; Claire Falandry
Journal:  Curr Oncol Rep       Date:  2018-06-13       Impact factor: 5.075

9.  Response to the letter to the Editor concerning our article "High adherence of patients with multiple myeloma who receive treatment with immunomodulatory drugs (IMIDS) in hematology/oncology group practices in Germany".

Authors:  Stefan Feiten; Geothy Chakupurakal; Hans Peter Feustel; Michael Maasberg; Burkhard Otremba; Peter Ehscheidt; Manfred Hensel; Richard Hansen; Rudolf Weide
Journal:  Support Care Cancer       Date:  2019-11-08       Impact factor: 3.603

10.  The role of family confidants and caregivers in the care of older cancer patients: Extending the concept of "shared decision-making".

Authors:  Frank Gieseler; Andreas Heidenreich; Jacqueline Schubert; Fabian Frielitz; Christoph Rehmann-Sutter; Frank Wörler; Christina Schües; Joachim Hübner; Susanne Elsner; Katarina Block; Achim Rody; Nikolas von Bubnoff; Tobias Keck; Monika Steimann; Gero Endsin; Alexander Katalinic
Journal:  Health Sci Rep       Date:  2021-05-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.